Latin America Hip Fracture Mortality Study

This is a multi-center, prospective, observational clinical study to evaluate mortality in patients with surgically-treated hip fracture in Latin America, and investigate associated prognostic factors. Patients will be followed for 12 months.

Inclusion criteria

• Adults 60 years and older
• Diagnosis of an isolated intertrochanteric fracture (AO 31-A) confirmed by radiographic evaluation
• Primary surgical fracture treatment within 10 days after trauma
• No prior treatment for the fracture
• Ability to understand the content of the patient information / informed consent form
• Willingness and ability to participate in the clinical investigation according to the CIP
• Signed and dated IRB/EC-approved written informed consent

Exclusion criteria

• Polytrauma (ie, multiple injuries, whereof one or the combination of several injuries is life threatening)
• Pathologic fracture due to a disease other than osteoporosis (eg, tumor, metastasis)
• Active malignancy
• Class 5 and 6 of the American Society of Anesthesiologists (ASA) physical status classification (Appendix 2)
• Neurological and/or psychiatric disorders that would preclude reliable assessment (eg, Parkinson's disease, multiple sclerosis, severe depression)
• Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment
• Prisoner
• Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
• Noncompletion of patient baseline questionnaires
• Prior implant on the fractured hip